Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 112 articles:
HTML format
Text format



Single Articles


    November 2017
  1. PALMER JR, Castro-Webb N, Bertrand K, Bethea TN, et al
    Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.
    Cancer Res. 2017;77:6462-6469.
    PubMed     Text format     Abstract available


    October 2017
  2. PATIN EC, Soulard D, Fleury S, Hassane M, et al
    Type I IFN receptor signalling controls IL-7-dependent accumulation and activity of protumoral IL-17A-producing gammadeltaT cells in breast cancer.
    Cancer Res. 2017 Oct 25. pii: canres.1416.2017.
    PubMed     Text format     Abstract available


  3. TURCOTTE M, Allard D, Mittal D, Bareche Y, et al
    CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
    Cancer Res. 2017;77:5652-5663.
    PubMed     Text format     Abstract available


    September 2017
  4. ISHIHARA S, Inman DR, Li WJ, Ponik SM, et al
    Mechano-signal transduction in mesenchymal stem cells induces prosaposin secretion to drive the proliferation of breast cancer cells.
    Cancer Res. 2017 Sep 28. pii: canres.0569.2017.
    PubMed     Text format     Abstract available


  5. YANG A, Qin S, Schulte BA, Ethier SP, et al
    MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer.
    Cancer Res. 2017 Sep 26. pii: canres.3452.2016.
    PubMed     Text format     Abstract available


  6. TEO ZL, Versaci S, Dushyanthen S, Caramia F, et al
    Combined CDK4/6 and PI3Kalpha inhibition is synergistic and immunogenic in triple negative breast cancer.
    Cancer Res. 2017 Sep 25. pii: canres.2210.2017.
    PubMed     Text format     Abstract available


  7. CHEN L, Chubak J, Boudreau DM, Barlow WE, et al
    Diabetes treatments and risks of adverse breast cancer outcomes among early stage breast cancer patients: A SEER-Medicare analysis.
    Cancer Res. 2017 Sep 21. pii: canres.0687.2017.
    PubMed     Text format     Abstract available


  8. DAVIES H, Morganella S, Purdie CA, Jang SJ, et al
    Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency.
    Cancer Res. 2017;77:4755-4762.
    PubMed     Text format     Abstract available


  9. KATZENELLENBOGEN BS, Zhao Y, Laws MJ, Sanabria Guillen V, et al
    Structurally novel antiestrogens elicit differential responses from constitutively active mutant estrogen receptors in breast cancer cells and tumors.
    Cancer Res. 2017 Sep 13. pii: canres.1265.2017.
    PubMed     Text format     Abstract available


  10. DETHLEFSEN C, Hansen LS, Lillelund C, Andersen C, et al
    Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development.
    Cancer Res. 2017 Sep 8. doi: 10.1158/0008-5472.CAN-16-3125.
    PubMed     Text format     Abstract available


  11. METZGER E, Stepputtis SS, Strietz J, Preca BT, et al
    KDM4 inhibition targets breast cancer stem-like cells.
    Cancer Res. 2017 Sep 7. pii: canres.1754.2017.
    PubMed     Text format     Abstract available


    August 2017
  12. ROSS MH, Esser AK, Fox GC, Schmieder AH, et al
    Bone-induced expression of integrin beta3 enables targeted nanotherapy of breast cancer metastases.
    Cancer Res. 2017 Aug 30. pii: canres.1225.2017.
    PubMed     Text format     Abstract available


  13. LI J, Gao Z, Zhao D, Zhang L, et al
    PI-273, a substrate-competitive, specific small molecule inhibitor of PI4KIIalpha, inhibits the growth of breast cancer cells.
    Cancer Res. 2017 Aug 21. pii: canres.0484.2017.
    PubMed     Text format     Abstract available


  14. SAHNI JM, Gayle SS, Webb B, Weber-Bonk KL, et al
    Mitotic vulnerability in triple-negative breast cancer associated with LIN9 is targetable with BET inhibitors.
    Cancer Res. 2017 Aug 14. pii: canres.1571.2017.
    PubMed     Text format     Abstract available


  15. CHAN CHT, Munusamy P, Loke SY, Koh GL, et al
    Identification of Novel Breast Cancer Risk Loci.
    Cancer Res. 2017 Aug 3. pii: canres.0992.2017.
    PubMed     Text format     Abstract available


    July 2017
  16. REGGIANI F, Labanca V, Mancuso P, Rabascio C, et al
    Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression.
    Cancer Res. 2017 Jul 28. pii: canres.0914.2017.
    PubMed     Text format     Abstract available


  17. FINLAY-SCHULTZ J, Gillen AE, Brechbuhl HM, Ivie JJ, et al
    Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III.
    Cancer Res. 2017 Jul 20. pii: canres.3541.2016.
    PubMed     Text format     Abstract available


  18. RANGEL R, Guzman-Rojas L, Kodama T, Kodama M, et al
    Identification of new tumor suppressor genes in triple-negative breast cancer.
    Cancer Res. 2017 Jul 19. pii: canres.0785.2017.
    PubMed     Text format     Abstract available


  19. SALVADOR F, Martin A, Lopez-Menendez C, Moreno-Bueno G, et al
    Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer.
    Cancer Res. 2017 Jul 18. pii: canres.3152.2016.
    PubMed     Text format     Abstract available


  20. SOSSEY-ALAOUI K, Pluskota E, Bialkowska K, Szpak D, et al
    Kindlin-2 regulates the growth of breast cancer tumors by activating CSF-1-mediated macrophage infiltration.
    Cancer Res. 2017 Jul 7. pii: canres.2337.2016.
    PubMed     Text format     Abstract available


    June 2017
  21. YOU E, Huh YH, Kwon A, Kim SH, et al
    SPIN90 depletion and Microtubule Acetylation Mediate Stromal Fibroblast Activation in Breast Cancer Progression.
    Cancer Res. 2017 Jun 26. pii: canres.0657.2017.
    PubMed     Text format     Abstract available


  22. SALEH SM, Bertos NR, Gruosso T, Gigoux M, et al
    Identification of interacting stromal axes in triple-negative breast cancer.
    Cancer Res. 2017 Jun 26. pii: canres.3427.2016.
    PubMed     Text format     Abstract available


  23. HUMPHRIES B, Wang Z, Li Y, Jhan JR, et al
    ARHGAP18 downregulation by miR-200b suppresses metastasis of triple negative breast cancer by enhancing activation of RhoA.
    Cancer Res. 2017 Jun 15. pii: canres.3141.2016.
    PubMed     Text format     Abstract available


  24. FLOWERS M, Birkey Reffey S, Mertz SA, Hurlbert M, et al
    Obstacles, Opportunities and Priorities for Advancing Metastatic Breast Cancer Research.
    Cancer Res. 2017 Jun 10. doi: 10.1158/0008-5472.CAN-17-0232.
    PubMed     Text format     Abstract available


    May 2017
  25. VALDEZ KE, Elsarraj HS, Hong Y, Grimm SL, et al
    NEMO, a transcriptional target of estrogen and progesterone, is linked to tumor suppressor PML in breast cancer.
    Cancer Res. 2017 May 17. pii: canres.2794.2016.
    PubMed     Text format     Abstract available


  26. BARTON VN, Christenson JL, Gordon MA, Greene LI, et al
    Androgen receptor supports an anchorage-independent, cancer stem cell-like population in triple-negative breast cancer.
    Cancer Res. 2017 May 16. pii: canres.3240.2016.
    PubMed     Text format     Abstract available


  27. HOLM J, Eriksson L, Ploner A, Eriksson M, et al
    Assessment of breast cancer risk factors reveals subtype heterogeneity.
    Cancer Res. 2017 May 16. pii: canres.2574.2016.
    PubMed     Text format     Abstract available



  28. Correction: UTX and MLL4 Coordinately Regulate Transcriptional Programs for Cell Proliferation and Invasiveness in Breast Cancer Cells.
    Cancer Res. 2017;77:2553.
    PubMed     Text format    


    April 2017
  29. LI B, Ni Chonghaile T, Fan Y, Madden S, et al
    THERAPEUTIC RATIONALE TO TARGET HIGHLY EXPRESSED CDK7 CONFERRING POOR OUTCOMES IN TRIPLE-NEGATIVE BREAST CANCER.
    Cancer Res. 2017 Apr 28. pii: canres.2546.2016.
    PubMed     Text format     Abstract available


  30. SAFONOV A, Jiang T, Bianchini G, Gyorffy B, et al
    Immune gene expression is associated with genomic aberrations in breast cancer.
    Cancer Res. 2017 Apr 20. pii: canres.3478.2016.
    PubMed     Text format     Abstract available


  31. LU K, Alcivar AL, Ma J, Foo TK, et al
    NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction.
    Cancer Res. 2017 Apr 17. pii: canres.2204.2016.
    PubMed     Text format     Abstract available


  32. WANG H, Schaefer T, Konantz M, Braun M, et al
    Prominent Oncogenic Roles of EVI1 in Breast Carcinoma.
    Cancer Res. 2017;77:2148-2160.
    PubMed     Text format     Abstract available


  33. SANSONE P, Berishaj M, Rajasekhar VK, Ceccarelli C, et al
    Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.
    Cancer Res. 2017;77:1927-1941.
    PubMed     Text format     Abstract available


  34. GAGGIANESI M, Turdo A, Chinnici A, Lipari E, et al
    IL-4 primes the dynamics of breast cancer progression via DUSP4 inhibition.
    Cancer Res. 2017 Apr 11. pii: canres.3126.2016.
    PubMed     Text format     Abstract available


  35. HANKER AB, Estrada MV, Bianchini G, Moore PD, et al
    Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer.
    Cancer Res. 2017 Apr 10. pii: canres.2808.2016.
    PubMed     Text format     Abstract available


    March 2017
  36. TEMKO DP, Cheng YK, Polyak K, Michor F, et al
    Mathematical modeling links pregnancy-associated changes and breast cancer risk.
    Cancer Res. 2017 Mar 30. pii: canres.2504.2016.
    PubMed     Text format     Abstract available


  37. LIAO L, Song M, Li X, Tang L, et al
    E3 ubiquitin ligase UBR5 drives the growth and metastasis of triple negative breast cancer.
    Cancer Res. 2017 Mar 22. pii: canres.2409.2016.
    PubMed     Text format     Abstract available


  38. SHIMELIS H, Mesman RL, Von Nicolai C, Ehlen A, et al
    BRCA2 hypomorphic missense variants confer moderate risks of breast cancer.
    Cancer Res. 2017 Mar 10. pii: canres.2568.2016.
    PubMed     Text format     Abstract available


  39. HARRIS HR, Willett WC, Vaidya RL, Michels KB, et al
    An Adolescent and Early Adulthood Dietary Pattern Associated with Inflammation and the Incidence of Breast Cancer.
    Cancer Res. 2017;77:1179-1187.
    PubMed     Text format     Abstract available


  40. JANSEN VM, Bhola NE, Bauer JA, Formisano L, et al
    Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer.
    Cancer Res. 2017 Mar 1. pii: canres.2653.2016.
    PubMed     Text format     Abstract available


  41. CEJALVO JM, Martinez de Duenas E, Galvan P, Garcia-Recio S, et al
    Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer.
    Cancer Res. 2017 Mar 1. pii: canres.2717.2016.
    PubMed     Text format     Abstract available


  42. KA NL, Na TY, Na H, Lee MH, et al
    NR1D1 recruitment to sites of DNA damage inhibits repair and is associated with chemosensitivity of breast cancer.
    Cancer Res. 2017 Mar 1. pii: canres.2099.2016.
    PubMed     Text format     Abstract available


  43. ANJANAPPA M, Cardoso AA, Cheng L, Mohamad S, et al
    Individualized breast cancer characterization through single cell analysis of tumor and adjacent-normal cells.
    Cancer Res. 2017 Mar 1. pii: canres.3308.2016.
    PubMed     Text format     Abstract available


    February 2017
  44. RUPRECHT B, Zaal EA, Zecha J, Wu W, et al
    Lapatinib resistance in breast cancer cells is accompanied by phosphorylation-mediated reprogramming of glycolysis.
    Cancer Res. 2017 Feb 16. pii: canres.2976.2016.
    PubMed     Text format     Abstract available


  45. BAI L, Zhou B, Yang CY, Ji J, et al
    Targeted degradation of BET proteins in triple-negative breast cancer.
    Cancer Res. 2017 Feb 16. pii: canres.2622.2016.
    PubMed     Text format     Abstract available


  46. JACKSON W, Sosnoski DM, Ohanessian SE, Chandler P, et al
    The Role of Megakaryocytes in Breast Cancer Metastasis to Bone.
    Cancer Res. 2017 Feb 15. pii: canres.1084.2016.
    PubMed     Text format     Abstract available


  47. ZHOU R, Pantel AR, Li S, Lieberman BP, et al
    [18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple Negative Breast Cancer in Response to Glutaminase Inhibition.
    Cancer Res. 2017 Feb 15. pii: canres.1945.2016.
    PubMed     Text format     Abstract available


    January 2017
  48. WU Y, Yu X, Yi X, Wu K, et al
    Aberrant phosphorylation of SMAD4 Thr277-mediated USP9x-SMAD4 interaction by free fatty acids promotes breast cancer metastasis.
    Cancer Res. 2017 Jan 23. pii: canres.2012.2016.
    PubMed     Text format     Abstract available


  49. SUAREZ-CABRERA C, Quintana RM, Bravo A, Casanova ML, et al
    A transposon-based analysis reveals RASA1 is involved in triple negative breast cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1586.2016.
    PubMed     Text format     Abstract available


    December 2016
  50. SAMPSON JN, Falk RT, Schairer C, Moore SC, et al
    Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.
    Cancer Res. 2016 Dec 23. pii: canres.1717.2016.
    PubMed     Text format     Abstract available


    November 2016
  51. JAEGER S, Igea A, Arroyo R, Alcalde V, et al
    Quantification of pathway crosstalk reveals novel synergistic drug combinations for breast cancer.
    Cancer Res. 2016 Nov 22. pii: canres.0097.2016.
    PubMed     Text format     Abstract available


  52. SHIBATA T, Watari K, Izumi H, Kawahara A, et al
    Breast cancer resistance to antiestrogens is enhanced by increased ER degradation and ERBB2 expression.
    Cancer Res. 2016 Nov 22. pii: canres.1593.2016.
    PubMed     Text format     Abstract available


  53. KOCH M, de Jong JS, Glatz J, Symvoulidis P, et al
    Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer.
    Cancer Res. 2016 Nov 22. pii: canres.1773.2016.
    PubMed     Text format     Abstract available


  54. WANG L, Miyahira AK, Simons D, Lu X, et al
    IL-6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.
    Cancer Res. 2016 Nov 22. pii: canres.1373.2016.
    PubMed     Text format     Abstract available


  55. WALI VB, Langdon CG, Held MA, Platt JT, et al
    Systematic drug screening identifies tractable targeted combination therapies in triple-negative breast cancer.
    Cancer Res. 2016 Nov 21. pii: canres.1901.2016.
    PubMed     Text format     Abstract available


  56. PAIDI SK, Rizwan A, Zheng C, Cheng M, et al
    Label-Free Raman Spectroscopy Detects Stromal Adaptations in Premetastatic Lungs Primed by Breast Cancer.
    Cancer Res. 2016 Nov 15. doi: 10.1158/0008-5472.CAN-16-1862.
    PubMed     Text format     Abstract available


  57. DOWER CM, Bhat N, Wang EW, Wang HG, et al
    Selective Reversible Inhibition of Autophagy in Hypoxic Breast Cancer Cells Promotes Pulmonary Metastasis.
    Cancer Res. 2016 Nov 15. doi: 10.1158/0008-5472.CAN-15-3458.
    PubMed     Text format     Abstract available


  58. M ISMAIL TM, Bennett D, Platt-Higgins AM, Al-Medhtiy M, et al
    S100A4 elevation empowers expression of metastasis effector molecules in human breast cancer.
    Cancer Res. 2016 Nov 10. pii: canres.1802.2016.
    PubMed     Text format     Abstract available


  59. LI M, Yu X, Chen Q
    Chemopreventive effects of ROS targeting in a murine model of BRCA1-deficient breast cancer.
    Cancer Res. 2016 Nov 4. pii: canres.2350.2016.
    PubMed     Text format     Abstract available


    October 2016
  60. FORTNER RT, Schock H, Kaaks R, Lehtinen M, et al
    Human chorionic gonadotropin does not correlate with risk for maternal breast cancer: results from the Finnish maternity cohort.
    Cancer Res. 2016 Oct 26. pii: canres.1524.2016.
    PubMed     Text format     Abstract available


  61. METELLI A, Wu BX, Fugle CW, Rachidi S, et al
    Surface Expression of TGFbeta Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  62. CHIANG S, Weigelt B, Wen HC, Pareja F, et al
    IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  63. WEN SW, Sceneay J, Lima LG, Wong CS, et al
    The biodistribution and immune suppressive effects of breast cancer-derived exosomes.
    Cancer Res. 2016 Oct 19. pii: canres.0868.2016.
    PubMed     Text format     Abstract available



  64. Correction: Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.
    Cancer Res. 2016;76:6131-6132.
    PubMed     Text format    


  65. INGLE JN, Xie F, Ellis MJ, Goss PE, et al
    Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy.
    Cancer Res. 2016 Oct 10. pii: canres.1371.2016.
    PubMed     Text format     Abstract available



  66. Correction: Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.
    Cancer Res. 2016;76:5907.
    PubMed     Text format    


  67. COOK KL, Soto-Pantoja DR, Clarke PA, Cruz MI, et al
    Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer.
    Cancer Res. 2016;76:5657-5670.
    PubMed     Text format     Abstract available


    September 2016
  68. MARUSYK A, Tabassum D, Janiszewska M, Place A, et al
    Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes.
    Cancer Res. 2016 Sep 26. pii: canres.1457.2016.
    PubMed     Text format     Abstract available


  69. ANDRIEU G, Tran AH, Strissel KJ, Denis GV, et al
    BRD4 regulates breast cancer dissemination through Jagged1/Notch1 signaling.
    Cancer Res. 2016 Sep 20. pii: canres.0559.2016.
    PubMed     Text format     Abstract available


  70. RAO SS, Bushnell GG, Azarin SM, Spicer G, et al
    Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo.
    Cancer Res. 2016;76:5209-18.
    PubMed     Text format     Abstract available


  71. MENDELSOHN J
    Commentary on "Recombinant Humanized Anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts" (A Follow Up).
    Cancer Res. 2016;76:5192-4.
    PubMed     Text format    



  72. Correction: Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer.
    Cancer Res. 2016;76:5186.
    PubMed     Text format    


    August 2016
  73. LIM SK, Lu SY, Kang SA, Tan HJ, et al
    Wnt signaling promotes breast cancer by blocking ITCH-mediated degradation of the YAP/TAZ transcriptional coactivator WBP2.
    Cancer Res. 2016 Aug 30. pii: canres.3537.2016.
    PubMed     Text format     Abstract available


  74. BLISS SA, Sinha G, Sandiford O, Williams L, et al
    Mesenchymal stem cell-derived exosomes stimulates cycling quiescence and early breast cancer dormancy in bone marrow.
    Cancer Res. 2016 Aug 28. pii: canres.1092.2016.
    PubMed     Text format     Abstract available


  75. AIROLDI I, Cocco C, Sorrentino C, Angelucci D, et al
    Interleukin-30 promotes breast cancer growth and progression.
    Cancer Res. 2016 Aug 22. pii: canres.0189.2016.
    PubMed     Text format     Abstract available


  76. ELIASSEN AH, Warner ET, Rosner B, Collins LC, et al
    Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years.
    Cancer Res. 2016 Aug 16. pii: canres.0353.2016.
    PubMed     Text format     Abstract available


  77. TROMBERG BJ, Zhang Z, Leproux A, O'Sullivan TD, et al
    Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging (DOSI).
    Cancer Res. 2016 Aug 15. pii: canres.0346.2016.
    PubMed     Text format     Abstract available


  78. PANG MF, Siedlik MJ, Han S, Stallings-Mann M, et al
    Tissue stiffness and hypoxia modulate the integrin-linked kinase ILK to control breast cancer stem-like cells.
    Cancer Res. 2016 Aug 8. pii: canres.0579.2016.
    PubMed     Text format     Abstract available


  79. FISKUS W, Coothankandaswamy V, Chen J, Ma H, et al
    SIRT2 deacetylates and inhibits the peroxidase activity of peroxiredoxin-1 to sensitize breast cancer cells to oxidant stress inducing agents.
    Cancer Res. 2016 Aug 8. pii: canres.0126.2016.
    PubMed     Text format     Abstract available


  80. HU DG, Selth L, Tarulli G, Meech R, et al
    Androgen and estrogen receptors in breast cancer co-regulate human UDP-glucuronosyltransferases 2B15 and 2B17.
    Cancer Res. 2016 Aug 5. pii: canres.3372.2015.
    PubMed     Text format     Abstract available


  81. JONES LW, Kwan ML, Weltzien EK, Chandarlapaty S, et al
    Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early Stage Breast Cancer: The LACE and Pathways Studies.
    Cancer Res. 2016 Aug 3. pii: canres.3307.2015.
    PubMed     Text format     Abstract available


  82. YOLDI G, Pellegrini P, Trinidad EM, Cordero A, et al
    RANK signaling blockade reduces breast cancer recurrence by inducing tumor cell differentiation.
    Cancer Res. 2016 Aug 1. pii: canres.2745.2015.
    PubMed     Text format     Abstract available


    July 2016
  83. SCHMITZ J, Schwab J, Schwenck J, Chen Q, et al
    Decoding intratumoral heterogeneity of breast cancer by multiparametric in vivo imaging: A translational study.
    Cancer Res. 2016 Jul 27. pii: canres.0642.2015.
    PubMed     Text format     Abstract available


  84. JIA M, Andreassen T, Jensen L, Bathen TF, et al
    Estrogen receptor alpha promotes breast cancer by reprogramming choline metabolism.
    Cancer Res. 2016 Jul 25. pii: canres.2910.2015.
    PubMed     Text format     Abstract available


  85. KIM W, Takyar FM, Swan K, Jeong J, et al
    Calcium-sensing receptor (CaSR) promotes breast cancer by stimulating intracrine actions of parathyroid hormone-related protein.
    Cancer Res. 2016 Jul 22. pii: canres.2614.2015.
    PubMed     Text format     Abstract available


  86. TENG Y, Qin H, Bahssan A, Bendzunas G, et al
    The WASF3-NCKAP1-CYFIP1 complex is essential for breast cancer metastasis.
    Cancer Res. 2016 Jul 18. pii: canres.0562.2016.
    PubMed     Text format     Abstract available


  87. D'IPPOLITO E, Plantamura I, Bongiovanni L, Casalini P, et al
    MiR-9 and miR-200 regulate PDGFRbeta-mediated endothelial differentiation of tumor cells in triple negative breast cancer.
    Cancer Res. 2016 Jul 11. pii: canres.0140.2016.
    PubMed     Text format     Abstract available


    June 2016
  88. XING F, Liu Y, Sharma S, Wu K, et al
    Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer.
    Cancer Res. 2016 Jun 30. pii: canres.3541.2015.
    PubMed     Text format     Abstract available


  89. CHENG CT, Kuo CY, Ouyang C, Li CF, et al
    Metabolic stress-induced phosphorylation of KAP1 Ser473 blocks mitochondrial fusion in breast cancer cells.
    Cancer Res. 2016 Jun 30. pii: canres.2921.2015.
    PubMed     Text format     Abstract available


  90. ORSO F, Quirico L, Virga F, Penna E, et al
    miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer.
    Cancer Res. 2016 Jun 21. pii: canres.1322.2015.
    PubMed     Text format     Abstract available


  91. LEE H, Goodarzi H, Tavazoie Corresponding Author SF, Alarcon CR, et al
    TMEM2 is a SOX4 regulated gene that mediates metastatic migration and invasion in breast cancer.
    Cancer Res. 2016 Jun 21. pii: canres.2322.2015.
    PubMed     Text format     Abstract available


  92. PHAM E, Yin M, Peters CG, Lee CR, et al
    Preclinical efficacy of bevacizumab with CRLX101, an investigational nanoparticle-drug conjugate, in treatment of metastatic triple-negative breast cancer.
    Cancer Res. 2016 Jun 20. pii: canres.3435.2015.
    PubMed     Text format     Abstract available


  93. SADIK H, Korangath P, Nguyen N, Gyorffy B, et al
    HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells.
    Cancer Res. 2016 Jun 14. pii: canres.0774.2016.
    PubMed     Text format     Abstract available


  94. DOU Q, Chen HN, Wang K, Yuan K, et al
    Ivermectin induces cytostatic autophagy by blocking PAK1/Akt axis in breast cancer.
    Cancer Res. 2016 Jun 14. pii: canres.2887.2015.
    PubMed     Text format     Abstract available


  95. ITO K, Park SH, Nayak A, Byerly JH, et al
    PTK6 inhibition suppresses metastases of triple negative breast cancer via Snail-dependent E-cadherin regulation.
    Cancer Res. 2016 Jun 14. pii: canres.3445.2015.
    PubMed     Text format     Abstract available


  96. SAMANTA D, Park Y, Andrabi SA, Shelton LM, et al
    PHGDH Expression is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance and Lung Metastasis.
    Cancer Res. 2016 Jun 8. pii: canres.0530.2016.
    PubMed     Text format     Abstract available


    May 2016
  97. SHAVER TM, Lehmann BD, Beeler JS, Li CI, et al
    Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies.
    Cancer Res. 2016 May 26. pii: canres.0058.2016.
    PubMed     Text format     Abstract available


  98. MANSOUR M, Haupt S, Chan AL, Godde N, et al
    E3 ligase E6AP represses breast cancer metastasis via regulation of ECT2-Rho signalling.
    Cancer Res. 2016 May 26. pii: canres.1553.2015.
    PubMed     Text format     Abstract available


  99. CHANG TY, Chen HA, Chiu CF, Chang YW, et al
    Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL.
    Cancer Res. 2016 May 23. pii: canres.2555.2015.
    PubMed     Text format     Abstract available


  100. SINGH M, Mukundan S, Jaramillo M, Oesterreich S, et al
    Three-dimensional breast cancer models mimic hallmarks of size-induced tumor progression.
    Cancer Res. 2016 May 23. pii: canres.2304.2015.
    PubMed     Text format     Abstract available


  101. VACCHELLI E, Enot DP, Pietrocola F, Zitvogel L, et al
    Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  102. MARSH T, Wong I, Sceneay J, Barakat A, et al
    Hematopoietic Age at Onset of Triple-Negative Breast Cancer Dictates Disease Aggressiveness and Progression.
    Cancer Res. 2016;76:2932-2943.
    PubMed     Text format     Abstract available


  103. LATORRE E, Carelli S, Raimondi I, D'Agostino V, et al
    The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
    Cancer Res. 2016;76:2626-2636.
    PubMed     Text format     Abstract available


    April 2016
  104. BHAT-NAKSHATRI P, Goswami CP, Badve S, Magnani L, et al
    Molecular Insights of Pathways Resulting From Two Common PIK3CA Mutations in Breast Cancer.
    Cancer Res. 2016 Apr 25. pii: canres.3174.2015.
    PubMed     Text format     Abstract available


  105. KNUTSON KL, Clynes R, Shreeder B, Yeramian P, et al
    Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain.
    Cancer Res. 2016 Apr 20. pii: canres.3091.2015.
    PubMed     Text format     Abstract available


  106. YEO SK, Wen J, Chen S, Guan JL, et al
    Autophagy differentially regulates distinct breast cancer stem-like cells in murine models via EGFR/Stat3 and Tgfss/Smad signaling.
    Cancer Res. 2016 Apr 13. pii: canres.2946.2015.
    PubMed     Text format     Abstract available


  107. CICHON MA, Moruzzi ME, Shqau TA, Miller E, et al
    MYC is a crucial mediator of TGFbeta-induced invasion in basal breast cancer.
    Cancer Res. 2016 Apr 13. pii: canres.3465.2015.
    PubMed     Text format     Abstract available


  108. ALHOSSINY M, Luo L, Frazier WR, Steiner N, et al
    Ly6E/K Signaling to TGFbeta Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  109. PENG D, Tanikawa T, Li W, Zhao L, et al
    Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL-6/STAT3 and NO/NOTCH cross-talk signaling.
    Cancer Res. 2016 Apr 6. pii: canres.2528.2015.
    PubMed     Text format     Abstract available


  110. LI Y, Jin K, van Pelt GW, van Dam H, et al
    c-Myb enhances breast cancer invasion and metastasis through the Wnt/beta-catenin/Axin2 pathway.
    Cancer Res. 2016 Apr 5. pii: canres.2302.2015.
    PubMed     Text format     Abstract available


    March 2016
  111. JOHNSON N, De Ieso P, Migliorini G, Orr N, et al
    Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  112. COX TR, Gartland A, Erler JT
    Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis.
    Cancer Res. 2016;76:188-92.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: